Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (5549)	1/22/1999 11:39:00 AM
From: Laz	Read Replies (1) \| Respond to of 122087

I was actually able to sell this one @ dlj... Laz

To: Anthony@Pacific who wrote (5549)	1/22/1999 11:43:00 AM
From: jjs64	Read Replies (1) \| Respond to of 122087

Here is SBTK's latest FDA violation...there are LOTS more. check fda.gov FDA Enforcement Report The FDA Enforcement Report is published weekly by the Food and Drug Administration, U.S. Public Health Service, Department of Health and Human Services. It contains information on actions taken in connection with agency regulatory activities. December 23, 1998 98-51 RECALLS AND FIELD CORRECTIONS: DEVICES -- CLASS II PRODUCT: Flush Syringe Combination Package, 10u/ml. Recall #Z-172-9. CODE:Lot number 10080-0821-1310-FL. MANFACTURER: ROCAP Division of Sabratek Corporation, Orlando, Florida. REASON: Some syringes labeled 10u/mL heparin actually contained normal saline. Now that's quality control!